Journal List > Korean J Physiol Pharmacol > v.25(1) > 1145604

TOOLS
Son, Oh, Lee, Choi, Lee, Park, Park, Son, and Byun: Gamma-aminobutyric acid-salt attenuated high cholesterol/high salt diet induced hypertension in mice
Original Article

Korean J. Physiol. Pharmacol. 2021;25(1):27-38.

Published online: 1 January 2021

DOI: https://doi.org/10.4196/kjpp.2021.25.1.27

Gamma-aminobutyric acid-salt attenuated high cholesterol/high salt diet induced hypertension in mice

Myeongjoo Son1, 2, #, Seyeon Oh2, #, Hye Sun Lee2, Junwon Choi1, 2, Bae-Jin Lee3, Joung-Hyun Park3, Chul Hyun Park4, Kuk Hui Son4, *, Kyunghee Byun1, 2, *

1Department of Anatomy and Cell Biology, Gachon University College of Medicine, Incheon 21999, Korea

2Functional Cellular Networks Laboratory, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Korea

3Marine Bioprocess Co., Ltd., Busan 46048, Korea

4Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University, Incheon 21565, Korea

*Correspondence Kyunghee Byun, E-mail: khbyun1@gachon.ac.kr, Kuk Hui Son, E-mail: dr632@gilhospital.com

Equal contributor:

# These authors contributed equally to this work.

Received 9 March 2020       Revised 4 October 2020       Accepted 11 October 2020

Copyright © Korean J Physiol Pharmacol

(open-access):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Excessive salt intake induces hypertension, but several gamma-aminobutyric acid (GABA) supplements have been shown to reduce blood pressure. GABA-salt, a fermented salt by L. brevis BJ20 containing GABA was prepared through the post-fermentation with refined salt and the fermented GABA extract. We evaluated the effect of GABA-salt on hypertension in a high salt, high cholesterol diet induced mouse model. We analyzed type 1 macrophage (M1) polarization, the expression of M1 related cytokines, GABA receptor expression, endothelial cell (EC) dysfunction, vascular smooth muscle cell (VSMC) proliferation, and medial thicknesses in mice model. GABA-salt attenuated diet-induced blood pressure increases, M1 polarization, and TNF-α and inducible nitric oxide synthase (NOS) levels in mouse aortas, and in salt treated macrophages in vitro. Furthermore, GABA-salt induced higher GABAB receptor and endothelial NOS (eNOS) and eNOS phosphorylation levels than those observed in salt treated ECs. In addition, GABA-salt attenuated EC dysfunction by decreasing the levels of adhesion molecules (E-selectin, Intercellular Adhesion Molecule-1 [ICAM-1], vascular cell adhesion molecule-1 [VCAM-1]) and of von Willebrand Factor and reduced EC death. GABA-salt also reduced diet-induced reductions in the levels of eNOS, phosphorylated eNOS, VSMC proliferation and medial thickening in mouse aortic tissues, and attenuated Endothelin-1 levels in salt treated VSMCs. In summary, GABA-salt reduced high salt, high cholesterol diet induced hypertension in our mouse model by reducing M1 polarization, EC dysfunction, and VSMC proliferation.

Keywords: Blood pressure, Endothelial cells, Gamma-aminobutyric acid (GABA)-salt, Macrophage polarization, Smooth muscle cells

INTRODUCTION

Elevated blood pressure act as major risks of stroke, cardiovascular diseases, and kidney failure, which are leading causes of death globally [1], and it is known that increased salt consumption, caused by increased consumption of sodium-rich fast foods, induces serious health conditions [1].
Experimental studies showed that high-salt containing diets are related with hypertension development and induce cardiovascular diseases in hypertensive animals [2-4]. In normotensive rodent animals, high-salt diets have been reported to induce structural changes of arterioles, reduction of microvascular density, and impaired skeletal muscle vessel relaxation by vasodilatory stimuli [2,5-7].
It has not been established how salt induces hypertension, but many studies showed macrophage involvement in its pathogenesis. Circulating monocytes from hypertensive patients showed more pro-inflammatory phenotype than normotensive controls [8,9], and hypertensive patients showed higher levels of interleukin (IL)-2, IL-6, IL-8, IL-1β, IL-1α, IL-18, tumor necrosis factor-alpha (TNF-α), interferon gamma (IFN-γ), and monocyte chemoattractant protein-1, C-reactive protein (CRP) [10,11].
These inflammatory cytokines are involved in macrophage polarization, as defined by two phenotypes, that is, the macrophage type 1 (M1) and type 2 (M2) phenotype (pro- and anti-inflammatory phenotypes, respectively). The M1 phenotype induces pro-inflammatory mediators, such as, IL-6, TNF-α, and inducible nitric oxide synthase (iNOS) [12-14], whereas the M2 phenotype reduces responsiveness to IFN-γ which leads to the inductions of low levels of pro-inflammatory mediators and the upregulations of IL-10 and arginase-1 (Arg-1) [12,13,15]. Interestingly, one study demonstrated that macrophages which cultured in sodium-chloride enriched medium showed polarization toward M1 phenotype [16].
Gamma-aminobutyric acid (GABA) is a non-protein amino acid which acts as main inhibitory neurotransmitter in the central nervous system. Furthermore, the GABA has been reported to have hypotensive effects [17], for example, low-dose oral GABA taking has been reported to have a hypotensive effect in Wistar-Kyoto rats and spontaneously hypertensive rats [18]. The role played by GABA in cardiovascular diseases, such as, hypertension remains to be clarified, although it has been suggested it reduces the productions of some classical pro-inflammatory cytokines and regulates immune responses [18]. One study showed GABA-overexpressing white mice had lower morning systolic blood pressures (BPs) than control mice [19], which suggested GABA supplementation in food might reduce hypertension. Furthermore, several studies have demonstrated various food products containing GABA showed blood pressure decreasing effects in hypertensive patients [17,20-22]. GABA-salt is a fermented salt containing GABA prepared by fermentation with Lactobacillus brevis BJ20 as an alternative for the traditional salt, known as a cause of cardiovascular diseases, especially hypertension induced by sodium sensitivity [23,24]. GABA-salt and low sodium GABA-salt were previously prepared through the fermentation with Lactobacillus brevis [25,26]
In this study, we produced a GABA-salt by mixing the fermented solution containing GABA with refined salt and post-fermentation. We evaluated the effect of GABA-salt on hypertension in a high salt and high cholesterol diet (HCD)-induced mouse model of hypertension. We hypothesized GABA in the GABA-salt might reduce classical pro-inflammatory cytokines induced by M1 polarization and that this would attenuate hypertension.

METHODS

Preparation of GABA-salt

Lactobacillus brevis BJ20 was inoculated into a seed medium (3% yeast extract, 1% glucose, 1% monosodium glutamate, 95% water) previously sterilized at 121°C for 15 min by autoclaving. Ten percentage (v/v) seed medium previously cultured at 37°C for 24 h was inoculated into a sterilized main culture medium (2% yeast extract, 1% glucose, 6% L-glutamic acid, 91% water), fermented at 37°C for 24 h. Fermented solution was further fermented with 40% (w/w) refined salt for 6 h and then filtered (Advantec MFS Inc., Dublin, CA, USA) and spray dried to yield GABA-salt.
The refined salt (Hanju Corp., Yangju, Korea), which has been removed most of the impurities through filtration, precipitation and concentration processes using a large amount of seawater was purchased from a local market.
A DIONEX Ultimate 3000 HPLC system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a UV detector was used to confirm the presence and to determine the level of GABA in GABA-salt. The GABA-salt was diluted with distilled water to 1,000 mg/L. Gradient elution was performed with distilled water to 500, 250, 125, 62.5, 31.25, 15.625 ppm of standard solution. Four percentage of GABA-salt solution was diluted with distilled water then eluted 50 times with 0.02 N hydrochloric acid and passed through a membrane filter. The column was operated in descending mode at a flow rate of 1.0 ml/min and injection volume was 20 µl. Ultra-high-performance liquid chromatograph was performed using a two-phase solvent system comprised of 50 mM sodium acetate (pH 6.5, solution A) and acetonitrile/methanol/water (45:45:10 v/v/v, solution B). Zero minute, 90% of solution A and 10% of solution B and to 12 min, 60% of solution A and 40% of solution B and to 16 min, 10% of solution A and 90% of solution B were used. The column flow rate was maintained at 1.0 ml/min and injection volume was 20 µl. The GABA content (%) of GABA-salt is calculated by dividing the concentration (ppm) of GABA in the test solution by the total concentration (ppm) of the test solution after HPLC analysis and multiplying by 100.

Animals and GABA-salt administration

Male C57BL/6N mice (7-week old) were purchased from Orient Bio (Seongnam, Korea) and maintained under controlled conditions (23°C, 50% of humidity), and a 12/12 h dark/light cycle. The mice were fed either normal chow diet (ND) or a HCD (Harlan Laboratories, Indianapolis, IN, USA) for 5 weeks. Considering that GABA contains 0.76% of GABA-salt, mice were orally administered eating water with ND (ND group), salt with HCD (HCD/salt group; 0.03 mg/kg/day) or GABA-salt with HCD (HCD/GABA-salt group; 0.034 mg/kg/day) during the same 5 weeks.
After this 5-week feeding period, we measured water intake, urine volume and serum creatinine and blood urea nitrogen (BUN) and mice were sacrificed in accordance with guideline issued by the Institutional Animal Care and Use Committee of Gachon University (approval number: LCDI-2018-0066). In additional, we measured systolic, diastolic, and mean artery pressure at 3, 4, and 5 weeks. The BPs were monitored using a non-invasive tail-cuff CODA system (Kent Scientific Corp., Torrington, CT, USA) according to the manufacturer’s directions.

Serum creatinine and BUN validation

When mice were sacrificed, whole blood was collected and serum was seperated using serum-separating tubes (BD Vacutainer; Thermo Fisher Scientific). The serum creatinine and BUN were measured using by ELISA kit according to the manufacturer’s directions (Abcam, Cambridge, UK).

Cell culture and in vitro model

Murine endothelial cells (SVEC 4–10) was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were grown in Dulbecco's modified Eagle's medium (DMEM; Hyclone, Chicago, IL, USA) supplemented with 10% fetal bovine serum (FBS; Merck Millipore, OH, USA) and 1% penicillin streptomycin (Hyclone). Murine vascular smooth muscle cells (MOVAS) were also purchased from the ATCC and grown in DMEM (Hyclone) supplemented with 10% FBS (Merck Millipore) and antibiotics 0.2 mg/ml G-418 (Sigma-Aldrich, Burlington, MA, USA). Murine macrophages (Raw 264.7) were purchased from the Korea Cell Line Bank (Seoul, Korea). The cells were grown in DMEM supplemented with 10% FBS and 1% penicillin streptomycin.
The SVEC 4–10, MOVAS and Raw 264.7 cells were treated with 20 mM salt or 20 mM GABA-salt at the same concentrations used in the animal experiment. The salt and GABA-salt were dissolved in cell culture medium and stored at –4°C.
To make M1 macrophage activation model, 1M refined salt (Hanju Corp.) solution which solved in distilled water is prepared. The salt solution was mixed and diluted with the media up to 20 mM concentration. Then the cell was incubated in culture plate for 4 days and harvested for experiments.

RNA extraction and cDNA synthesis

Total RNA in aorta tissue and cells was isolated using RNAiso Plus kits (TAKARA, Tokyo, Japan) [27]. Animal samples and cell samples are mixed with 0.2 ml of chloroform (Amresco, Solon, OH, USA) and then, centrifuged at 13,000 ×g for 15 min at 4°C. Clear part was collected into new tubes and mixed with 0.4 ml of 100% isopropanol and centrifuged at 13,000 ×g for 10 min at 4°C. Isolated RNA pellets were washed with 1 ml of 75% ethanol and centrifuged at 7,500 ×g for 5 min at 4°C. Dried pellets were dissolved in 10 to 50 µl diethyl pyrocarbonate (DEPC, Sigma-Aldrich) treated water and the prepared RNA was quantified using a Nanodrop 2000 (Thermo Fisher Scientific). Complementary DNA (cDNA) was synthesized from RNA using a cDNA synthesis kit (PrimeScript; TAKARA).

Quantitative real time polymerase chain reaction (qRT-PCR)

qRT-PCR was performed to determine mRNA levels. Briefly, primer and distilled water were first mixed and placed in 384-well plate. Template cDNA and SYBR green reagent (TAKARA) were then added to the well plate and spun down (Eppendorf, Hamburg, Germany). Mixed samples were validated using by qRT-PCR machine (Bio-Rad, Hercules, CA, USA). All genes of interest are listed in Supplementary Table 1.

Immunofluorescence for aortic tissues

Aorta paraffin block tissues were sectioned at 7 um and placed on slides, dried at 40°C for 24 h, de-paraffinized, and incubated in normal animal serum containing 0.03% triton X-100 to block antibody binding. Slides were then incubated with antibodies (listed in Supplementary Table 2) for 2 days at 4°C, rinsed 3 times with phosphate-buffered saline (PBS), incubated for 1 h at room temperature with fluorescence conjugated secondary antibodies, and rinsed 3 times with PBS. They were then incubated with 4´6-diamidino-2-phenylindole solution (DAPI; Sigma-Aldrich) at room temperature for 5 min, rinsed 3 times with PBS and mounted with cover slips using vector shield solution (Vector Laboratories, Burlingame, CA, USA). The fluorescent signal was detected using a confocal microscope (LSM 710; Carl Zeiss, Oberkochen, Germany).

Immunofluorescence for cells

SVEC 4–10 and MOVAS cells (104) were cultured in an 8-well chamber (Thermo Fisher Scientific) for 24 h, removed from medium, and rinsed 3 times with PBS. They were then fixed in cold 100% methanol (Duksan Company, Ansan, Korea) at room temperature for 15 min, rinsed 3 times with PBS, incubated in normal animal serum containing 0.03% triton X-100 to block antibody binding, incubated with antibodies (listed in Supplementary Table 2) at 4°C for 1 day, and then rinsed 3 times with PBS. The cells were then incubated for 1 h at room temperature with fluorescence conjugated secondary antibodies, rinsed 3 times with PBS, incubated for 5 min at room temperature in DAPI solution, and rinsed 3 times with PBS. Finally, the cells were mounted with cover slips using vector shield solution. The fluorescent signal was detected using a confocal microscope.

Immunohistochemistry using 3, 3´-diaminobenzidine

Aorta paraffin block slides were de-paraffinized and incubated with 0.3% H2O2 (Sigma-Aldrich) for 30 mins, rinsed 3 times with PBS, incubated in normal animal serum to block antibody binding, incubated with antibodies (listed in Supplementary Table 2) for 2 days at 4°C and then rinsed 3 times with PBS. Slides were then treated with biotinylated secondary antibodies in the ABC kit (Vector Laboratories), incubated for 1 h at room temperature in blocking solution, and rinsed 3 times with PBS. Slides were developed with 3, 3´-diaminobenzidine (DAB) substrate containing 0.3% H2O2 at room temperature for 15 min and mounted with cover slips using DPX mounting solution (Sigma-Aldrich). Stained images were visualized by light microscopy (Olympus Optical Co., Tokyo, Japan) [28].

Terminal deoxyribonucleotidyl transferase-mediated biotin-16-dUTP nick-end labelling assay

To count numbers of apoptotic endothelial cells on paraffin block slides of aortas, we used Terminal deoxyribonucleotidyl transferase (TdT)-mediated biotin-16-dUTP nick-end labelling (TUNEL) assay kit (TransGen Biotech Co., Ltd., Beijing, China). The slides were stained with DAPI solution (Sigma-Aldrich) at room temperature for 5 min, washed 3 times with PBS, and mounted with cover slips using vector shield solution (Vector Laboratories). The fluorescence was detected using a confocal microscope (LSM 710).

Histological H&E staining

Paraffin block slides of aortas were de-paraffinized, incubated in hematoxylin (DAKO, Carpinteria, CA, USA) for 1 min, rinsed with water for 3 min at room temperature, incubated with eosin (Sigma-Aldrich) for 15 sec, rinsed with water, and dehydrated using an alcohol gradient. Finally, slides were mounted with cover slips using DPX mounting solution and visualized by light microscopy (Olympus Optical Co.) [29]. Intima-media thickness ratios were measured using the Image J program (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

Results are presented as means ± standard deviation (SD). The significances of intergroup differences were determined using the Mann–Whitney U-test for multiple comparison and the Kruskal-Wallis test for post-hoc. The statistical analysis was conducted using SPSS 22 statistical software (IBM Co., Armonk, NY, USA), and statistical significance was accepted for p-values ≤ 0.05.

RESULTS

Composition of GABA-salt

The peak of GABA in base salt and GABA-salt on the high-performance liquid chromatography (HPLC) shown in Fig. 1. Mean GABA content of GABA-salt was 0.76% ± 0.01% (mean ± SD, Fig. 1C).

GABA-salt attenuated BP increases and renal function deterioration in hypertensive mice

Mean systolic BPs in the HCD/salt fed animals were significantly higher than in the ND controls at all time points during the 5-week experimental period. Mean systolic BP in HCD/GABA-salt fed animals was significantly lower than in HCD/salt fed animals at all time points. Mean systolic BPs of HCD/GABA-salt fed animals were higher than those of ND controls, but not significantly so (Fig. 2A). Mean diastolic BPs in HCD/salt fed animals were significantly higher than in ND controls at all time points. Mean diastolic BPs in HCD/GABA-salt fed animals were significantly lower than in HCD/salt fed animals at 4 and 5 weeks. Mean diastolic BPs in HCD/GABA-salt fed animals were higher than in ND controls, but not significantly so at any time point (Fig. 2B). Mean arterial pressures (MAPs) in HCD/salt fed animals were significantly higher than in ND controls at all time points. MAPs increase observed in HCD/salt fed animals were attenuated in GABA-salt fed animals (Fig. 2C). In additional, water intake (Fig. 2D) and urine volume (Fig. 2E) were in HCD/salt fed animals were significantly higher than in ND controls. The water intake and urine volume in HCD/GABA-salt fed animals were significantly lower than in HCD/salt fed animals at 5 weeks. In hypothalamus, primary osmoreceptors modulate arginine vasopressin (AVP) which regulates the tonicity of systemic fluids. The AVP mRNA level was in HCD/salt fed animals were significantly higher than in ND controls. The AVP level in HCD/GABA-salt fed animals was significantly lower than in HCD/salt fed animals at 5 weeks (Supplementary Fig. 1).
Interestingly, renal function test including creatinine (Fig. 2F) and BUN (Fig. 2G) serum level were in HCD/salt fed animals were significantly higher than in ND controls. The water intake and urine volume in HCD/GABA-salt fed animals were significantly lower than in HCD/salt fed animals at 5 weeks. Body weight among three groups was not statistically significant. Total cholesterol was statistically significant in HCD/salt group but decreased in HCD/GABA-salt group (Supplementary Fig. 2).

GABA-salt attenuated M1 polarization and cytokine secretion in the aortic tissues of hypertensive mice and in Raw 264.7 macrophage

Results of immunohistochemistry and qRT-PCR showed CD86 expression was significantly higher in HCD/salt fed animals than in ND controls, and that these increases were significantly less in HCD/GABA-salt fed animals (Fig. 3A, B and Supplementary Fig. 3). The expression of TNF-α (an M1 inflammatory cytokine) was higher in those of HCD/salt fed animals than in ND controls, but was significantly lower in HCD/GABA-salt fed animals than in HCD/salt fed animals, as determined by qRT-PCR and immunohistochemistry. iNOS expressed by M1 macrophages levels were higher in HCD/salt fed animals than in ND controls, and lower in HCD/GABA-fed animals than in HCD/salt fed animals (Fig. 3C). CD206 expression was significantly higher in HCD/salt fed animals than in ND controls. CD206 expression in HCD/GABA-salt fed animals was non-significantly lower than HCD/salt fed animals (Fig. 3D, E and Supplementary Fig. 3). Transforming growth factor beta 1 (TGF-β) secreted by M2 macrophages levels were lower in HCD/salt fed animals than in controls, but significantly higher in HCD/GABA-salt fed animals than in HCD/salt fed animals. Arg-1 levels expressed by M2 macrophages were lower in HCD/salt fed animals than in ND controls, but, Arg-1 level in HCD/GABA-salt fed animals was non-significantly higher than HCD/salt fed animals (Fig. 3F).
We also treated Raw 264.7 macrophages with salt or GABA-salt (Fig. 4). CD86 mRNA levels in salt treated macrophages were significantly higher than in media treated macrophages, but lower in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4A). CD206 expression reduced when macrophages were treated with salt but were higher in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4B). TNF-α expression in salt treated macrophages was significantly higher than in media treated macrophages, but lower in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4C). TGF-β expression in salt treated macrophages was significantly lower than in media treated macrophages, but higher in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4D).
The iNOS expression was higher in salt treated macrophages than in media treated macrophages, and lower in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4E). On the other hand, Arg-1 expression was lower in salt treated macrophages than in the media treated macrophages and substantially higher in GABA-salt treated macrophages than in salt treated macrophages (Fig. 4F).

GABA-salt preserved expressions of GABAB receptor, eNOS and of phosphorylated eNOS in endothelial cells and endothelial cell dysfunction and cell death in the aortas of hypertensive animals

GABAB receptor expression levels were lower in salt treated endothelial cell (ECs) than in media treated ECs, and GABA-salt attenuated these reductions in GABAB receptor expression (Fig. 5A). Immunohistochemistry results revealed that eNOS and phosphorylated eNOS levels were lower in salt treated ECs than in media treated ECs, and that their levels were higher in GABA-salt treated ECs than in salt treated ECs (Fig. 5B and Supplementary Fig. 4A). eNOS and phosphorylated eNOS levels were assessed immunohistochemically in aortic EC layers. The levels of both proteins were lower in HCD/salt fed animals than in ND controls, and levels were higher in HCD/GABA-salt fed animals than in HCD/salt fed animals (Fig. 5C and Supplementary Fig. 4B).
Protein levels of adhesion molecules, that is, E-selectin, Intercellular Adhesion Molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and von Willebrand Factor (vWF) were higher in endothelial layers in the HCD/salt fed animals than in ND controls, and lower in HCD/GABA-salt than in HCD/salt fed animals (Fig. 5D and Supplementary Fig. 4C). Endothelial cell death was greater in HCD/salt fed animals than in ND controls, and was lower in HCD/GABA-salt than in HCD/salt fed animals (Fig. 5E, F).

GABA-salt preserved GABAB receptor expression and attenuated Endothelin-1 expression in VSMCs and SMC proliferation and medial thickening in the aortas of hypertensive animals

GABAB receptor expression levels in salt treated VSMCs and ECs were lower than in their media treated counterparts, and higher in GABA-salt treated than in salt treated VSMCs and ECs. GABAB receptor expression was lower in salt treated ECs and VSMCs than in controls, but higher in GABA-salt treated ECs and VSMCs than in salt treated counterparts (Figs. 5A, 6A).
Immunohistochemistry results showed that Endothelin-1 (ET-1) expression levels in salt treated VSMCs were greater than in media treated VSMCs, and lower in GABA-salt treated VSMCs than in salt treated VSMCs (Fig. 6B and Supplementary Fig. 5). In this study, the ET-1 level was higher in salt treated VSMCs than in media treated VSMCs and lower in the GABA-salt treated VSMCs than salt treated VSMCs (Fig. 6B and Supplementary Fig. 5). Furthermore, SMC proliferation and medial thickening were attenuated in HCD/GABA-salt fed animals (Fig. 6C, D). Proliferating cell nuclear antigen (PCNA) staining was used to evaluate SMC proliferation in medial aortic layers. The PCNA expression in HCD/salt fed animals was higher than in ND controls, but lower in HCD/GABA-salt than in HCD/salt fed animals. In addition, intima-media ratios were higher in HCD/salt fed animals than in ND controls, and lower in HCD/GABA-salt than in HCD/salt fed animals (Fig. 6C, D). In the present study, PCNA staining showed SMC proliferation was greater in HCD/salt fed animals and that intima-media ratios were higher in the HCD/salt fed animals than in ND controls (Fig. 6C, D).

DISCUSSION

Several animal studies have demonstrated that consumption of high salt induces hypertension in rats and primates [30,31]. Similarly, BPs were increased in mice by HCD and salt in our study. It has been reported the risks of developing a high BP are increased by 14% and 27% when daily salt intakes are 12 or 18 g/day, respectively, as compared with a daily salt intake of 6 g/day [32,33]. It is difficult for Asians to reduce salt intake, because Asians put more salt or condiments containing salt such as soy sauce during cooking than Caucasians [32,33]. Thus, we believe that GABA-salt might provide those who find it difficult to reduce salt intake as a means of reducing BPs. Although the mechanism responsible for salt-induced hypertension has not been fully elucidated, several studies have shown NaCl stimuluses the secretions of TNF-α [34,35]. TNF-α is a typical M1 macrophage related cytokine and is secreted mainly by macrophages [36]. Thus, it seems that M1 macrophages or the cytokines they secrete might have a primary role in the hypertension induced by salt intake. In this study, CD 86 (a M1 macrophage marker) level and TNF-α and iNOS (expressed by M1 macrophages) levels were elevated in HCD/salt fed animals (Fig. 3). Furthermore, similar results were obtained from our in vitro studies, that are, salt treated macrophages polarized toward the M1 type and expressed more TNF-α and iNOS than media treated macrophages (Fig. 4). It has been reported iNOS expressed by M1 macrophages promote endothelial dysfunction [37], and that hypertension is related with EC dysfunctions lead to decreasing endothelial-dependent vasodilation and damage [38-42].
The pathophysiology of hypertension is not fully revealed, but several studies have shown that the inhibition of M1 macrophage activation causes BP normalization, which suggests the M1 phenotype is a key factor of hypertension [11,43,44]. In this study, TNF-α and iNOS were found to be over-expressed in hypertensive mice (in vivo, HCD/salt group) and in salt treated macrophages (in vitro, salt group), and these over-expressions of TNF-α and iNOS were attenuated by feeding animals HCD/GABA-salt (in vivo, HCD/GABA-salt group) and by treating macrophages with GABA-salt (in vitro, GABA-salt group).
In resting ECs, eNOS is primarily placed at cell membranes and in cytoplasm, and translocate close to the nucleus by agonists [45,46]. eNOS translocation leads to increase level of [Ca2+]i in ECs [47]. It has been shown GABAB receptors which expressed in cultured human arterial ECs regulate the translocations of eNOS and level of [Ca2+]i [47]. Furthermore, another study showed baclofen, agonist GABAB receptor, induced vasodilation of 50% of rat retina vessels, and that this vasodilation is inhibited by 2-hydroxysaclofen, the GABAB receptor antagonist [48].
Endothelial dysfunction leads to the increased expression levels of cell adhesion molecule (E-selectin, ICAM-1, and VCAM-1) [49], and it is known TNF-α enhanced the expressions of the adhesion molecules [50,51]. The E-selectin, ICAM-1, and VCAM-1 lead to leukocyte adhesion at inflamed sites [52], and these adhesion molecules lead to adhesion between leukocytes and ECs and transmigration into vessel walls [53]. In this study, E-selectin, ICAM-1, and VCAM-1 protein levels in aortic ECs were elevated in hypertensive animals. Furthermore, vWF expression was also elevated in hypertensive animals. vWF release is increased when ECs are damaged, thus, vWF is an indicator of endothelial dysfunction [54]. When eNOS is activated in ECs, it generates nitric oxide (NO) which leads to blood vessel dilation [55]. On the other hand, endothelial dysfunction reduces endothelium-dependent vasodilatory response and eNOS availability [56]. Phosphorylation at serine residue 1179 of eNOS increases enzymatic activity which lead to NO production [57], whereas TNF-α compromises endothelium-dependent vasodilation by reducing eNOS synthesis and activity, and thus, decreasing the bioavailability of NO [57]. In this study, the expressions of eNOS and phosphorylated eNOS were found to be lower in hypertensive mice.
EC apoptosis relates with SMC migration and proliferation, increase blood coagulation, increase leukocyte infiltration, and cause endothelial dysfunction [58]. In this study, EC death and endothelial dysfunction were greater in hypertensive animals. Furthermore, the factors that induce endothelial dysfunction, such as, adhesion molecule (E-selectin, ICAM-1, and VCAM-1) and vWF levels, and EC death were lower in HCD/GABA-salt that in HCD/salt fed animals. In addition, the protein levels of eNOS and phosphorylated eNOS, which have a protective effect on EC damage, were higher in HCD/GABA-salt than in HCD/salt fed animals.
VSMCs phenotype could changes from the contractile phenotype to the synthetic phenotype by hypertensive stress [59]. In addition, it is known that vascular wall is thickened by activated VSMCs which are accumulated in intima and media [60]. TNF-α induced the expression of cell adhesion molecules, such as VCAM-1, and lead to vascular inflammation, which enhance vascular fibrosis and SMC proliferation and subsequently increased arterial stiffness [59].
These results indicate GABA-salt reduces M1 polarization and the expression levels of M1 macrophage related factors (iNOS and TNF-α) as compared with salt. The iNOS and TNF-α are major triggering factors of endothelial dysfunction and VSMC proliferation, which are known to induce hypertension. Although our results did not allow access to mechanism responsible for the protective effect of GABA on EC function, they do suggest GABAB receptor expression attenuation by GABA increases eNOS activity and protects EC from salt induced injuries. It is also possible that GABA reduced salt-induced endothelial dysfunction by controlling TNF-α induced monocyte adhesion, as it has been reported an increase endogenous levels of GABA were associated with decrease in monocyte adhesion [60].
Taken together, our findings suggest GABA might affect eNOS function and modulate macrophage adhesion to ECs at high salt consumption levels by reducing TNF-α expression, and thus, reducing the expressions of adhesion molecules and NOS inhibition in ECs, and by possibly reducing the expression of ET-1, which participates in vasoconstriction and reduces VSMC proliferation, and thus, causes luminal narrowing or vascular stiffness. Finally, and perhaps the most important observation is that GABA-salt fed animals had significantly lower BP increases than salt fed animals. GABA-salt caused lower BP increases in hypertensive mice by modulating endothelial cell dysfunction and VSMC proliferation.

SUPPLEMENTARY MATERIALS

Supplementary data including five figures and two tables can be found with this article online at https://doi.org/10.4196/kjpp.2021.25.1.27.
kjpp-25-1-27_supple.pdf

ACKNOWLEDGEMENTS

This research was a part of the project titled ‘Development of fermented high GABA salts containing active lactic acid bacteria and their commercialization plan’, funded by the Ministry of Oceans and Fisheries, Korea (Grant No. 20200073).

Notes

Author contributions: H.S.L. and J.C. performed the cell-based assay experiments. M.S. and S.O. validated animal experiments. B.J.L. and J.H.P. prepared materials. K.H.S. and K.B. supervised and coordinated the study. M.S. and C.H.P. wrote the manuscript.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

REFERENCES

1. World Health Organization (WHO). 2009. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization;Geneva:
2. Liu G, Hitomi H, Rahman A, Nakano D, Mori H, Masaki T, Ma H, Iwamoto T, Kobori H, Nishiyama A. 2014; High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway. Hypertens Res. 37:13–18. DOI: 10.1038/hr.2013.108. PMID: 24026042. PMCID: PMC3947370.
crossref pmid
3. Manning RD Jr, Hu L, Tan DY, Meng S. 2001; Role of abnormal nitric oxide systems in salt-sensitive hypertension. Am J Hypertens. 14(6 Pt 2):68S–73S. DOI: 10.1016/S0895-7061(01)02072-6. PMID: 11411768.
crossref
4. Chiong M, Morales P, Torres G, Gutiérrez T, García L, Ibacache M, Michea L. 2013; Influence of glucose metabolism on vascular smooth muscle cell proliferation. Vasa. 42:8–16. DOI: 10.1024/0301-1526/a000243. PMID: 23385222.
crossref pmid
5. Liu Y, Rusch NJ, Lombard JH. 1999; Loss of endothelium and receptor-mediated dilation in pial arterioles of rats fed a short-term high salt diet. Hypertension. 33:686–688. DOI: 10.1161/01.HYP.33.2.686. PMID: 10024328.
crossref pmid
6. Frisbee JC, Sylvester FA, Lombard JH. 2001; High-salt diet impairs hypoxia-induced cAMP production and hyperpolarization in rat skeletal muscle arteries. Am J Physiol Heart Circ Physiol. 281:H1808–H1815. DOI: 10.1152/ajpheart.2001.281.4.H1808. PMID: 11557575.
crossref
7. Liu Y, Fredricks KT, Roman RJ, Lombard JH. 1997; Response of resistance arteries to reduced PO2 and vasodilators during hypertension and elevated salt intake. Am J Physiol. 273(2 Pt 2):H869–H877. DOI: 10.1152/ajpheart.1997.273.2.H869. PMID: 9277505.
crossref
8. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritsis D. 2002; Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol. 83:13–21. DOI: 10.1016/S0167-5273(02)00021-9. PMID: 11959378.
crossref pmid
9. Justin Rucker A, Crowley SD. 2017; The role of macrophages in hypertension and its complications. Pflugers Arch. 469:419–430. DOI: 10.1007/s00424-017-1950-x. PMID: 28251313. PMCID: PMC5773253.
crossref
10. Mirhafez SR, Mohebati M, Feiz Disfani M, Saberi Karimian M, Ebrahimi M, Avan A, Eslami S, Pasdar A, Rooki H, Esmaeili H, Ferns GA, Ghayour-Mobarhan M. 2014; An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J Am Soc Hypertens. 8:614–623. DOI: 10.1016/j.jash.2014.05.007. PMID: 25224864.
crossref pmid
11. Harwani SC. 2018; Macrophages under pressure: the role of macrophage polarization in hypertension. Transl Res. 191:45–63. DOI: 10.1016/j.trsl.2017.10.011. PMID: 29172035. PMCID: PMC5733698.
crossref pmid
12. Martinez FO, Helming L, Gordon S. 2009; Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 27:451–483. DOI: 10.1146/annurev.immunol.021908.132532. PMID: 19105661.
crossref pmid
13. Sica A, Mantovani A. 2012; Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 122:787–795. DOI: 10.1172/JCI59643. PMID: 22378047. PMCID: PMC3287223.
crossref pmid pmc
14. Lu G, Zhang R, Geng S, Peng L, Jayaraman P, Chen C, Xu F, Yang J, Li Q, Zheng H, Shen K, Wang J, Liu X, Wang W, Zheng Z, Qi CF, Si C, He JC, Liu K, Lira SA, et al. 2015; Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. Nat Commun. 6:6676. DOI: 10.1038/ncomms7676. PMID: 25813085. PMCID: PMC4389243.
crossref pmid pmc
15. Gordon S, Martinez FO. 2010; Alternative activation of macrophages: mechanism and functions. Immunity. 32:593–604. DOI: 10.1016/j.immuni.2010.05.007. PMID: 20510870.
crossref pmid
16. Hucke S, Eschborn M, Liebmann M, Herold M, Freise N, Engbers A, Ehling P, Meuth SG, Roth J, Kuhlmann T, Wiendl H, Klotz L. 2016; Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. J Autoimmun. 67:90–101. DOI: 10.1016/j.jaut.2015.11.001. PMID: 26584738.
crossref pmid
17. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M, Sansawa H. 2003; Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 57:490–495. DOI: 10.1038/sj.ejcn.1601555. PMID: 12627188.
pmid
18. Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa H, Yamori Y. 2004; Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr. 92:411–417. DOI: 10.1079/BJN20041221. PMID: 15469644.
pmid
19. Nishimura M, Yoshida S, Haramoto M, Mizuno H, Fukuda T, Kagami-Katsuyama H, Tanaka A, Ohkawara T, Sato Y, Nishihira J. 2015; Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure. J Tradit Complement Med. 6:66–71. DOI: 10.1016/j.jtcme.2014.11.022. PMID: 26870683. PMCID: PMC4738072.
crossref pmid pmc
20. Tanaka H, Watanabe K, Ma M, Hirayama M, Kobayashi T, Oyama H, Sakaguchi Y, Kanda M, Kodama M, Aizawa Y. 2009; The effects of gamma-aminobutyric acid, vinegar, and dried bonito on blood pressure in normotensive and mildly or moderately hypertensive volunteers. J Clin Biochem Nutr. 45:93–100. DOI: 10.3164/jcbn.09-04. PMID: 19590713. PMCID: PMC2704332.
pmid pmc
21. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M, Sansawa H. 2003; Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 57:490–495. DOI: 10.1038/sj.ejcn.1601555. PMID: 12627188.
pmid
22. Matsubara F, Ueno H, Tadano K, Suyama T, Imaizumi K, Suzuki T, Magata K, Kikuchi N, Muneyuki K, Nakamichi N, Kumagai H, Saruta T. 2002; Effects of GABA supplementation on blood pressure and safety in adults with mild hypertension. Jpn Pharmacol Ther. 30:963–972.
23. Weinberger MH, Fineberg NS. 1991; Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 18:67–71. DOI: 10.1161/01.HYP.18.1.67. PMID: 1860713.
crossref pmid
24. Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, Dart RA, Newton-Cheh CH, Sacks FM, Laffer CL. 2016; Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension. 68:e7–e46. DOI: 10.1161/HYP.0000000000000047. PMCID: PMC4900938. PMID: 27443572.
25. BJ Lee HS Song YS Kim MY Kim SJ Kwon . Marine Bioprocess Co., Ltd.2017. Jul. 20. Fermented salt containing GABA and preparing method thereof. Korea patent 10-1761710.
26. BJ Lee HS Song YS Kim MY Kim SJ Kwon . Marine Bioprocess Co., Ltd.2017. Jul. 20. Low salinity fermented salt containing GABA and preparing method thereof. Korea patent 10-1761711.
27. Bae JS, Oh AR, Lee HJ, Ahn YH, Cha JY. 2016; Hepatic Elovl6 gene expression is regulated by the synergistic action of ChREBP and SREBP-1c. Biochem Biophys Res Commun. 478:1060–1066. DOI: 10.1016/j.bbrc.2016.08.061. PMID: 27524233.
crossref
28. Kim OH, Booth CJ, Choi HS, Lee J, Kang J, Hur J, Jung WJ, Jung YS, Choi HJ, Kim H, Auh JH, Kim JW, Cha JY, Lee YJ, Lee CS, Choi C, Jung YJ, Yang JY, Im SS, Lee DH, et al. 2020; High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss. Elife. 9:e52709. DOI: 10.7554/eLife.52709. PMID: 32271147. PMCID: PMC7145417.
crossref
29. Lee EH, Itan M, Jang J, Gu HJ, Rozenberg P, Mingler MK, Wen T, Yoon J, Park SY, Roh JY, Choi CS, Park WJ, Munitz A, Jung Y. 2018; Eosinophils support adipocyte maturation and promote glucose tolerance in obesity. Sci Rep. 8:9894. DOI: 10.1038/s41598-018-28371-4. PMID: 29967467. PMCID: PMC6028436.
crossref pmid pmc
30. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. 1995; The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1:1009–1016. DOI: 10.1038/nm1095-1009. PMID: 7489355.
crossref pmid
31. Elliott P, Walker LL, Little MP, Blair-West JR, Shade RE, Lee DR, Rouquet P, Leroy E, Jeunemaitre X, Ardaillou R, Paillard F, Meneton P, Denton DA. 2007; Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation. 116:1563–1568. DOI: 10.1161/CIRCULATIONAHA.106.675579. PMID: 17785625.
pmid
32. Liu Y, Li H, Hong S, Yin X. 2015; Salt reduction and hypertension in China: a concise state-of-the-art review. Cardiovasc Diagn Ther. 5:191–196. DOI: 10.3978/j.issn.2223-3652.2015.05.01. PMID: 26090330. PMCID: PMC4451313.
pmid pmc
33. Brown IJ, Tzoulaki I, Candeias V, Elliott P. 2009; Salt intakes around the world: implications for public health. Int J Epidemiol. 38:791–813. DOI: 10.1093/ije/dyp139. PMID: 19351697.
crossref pmid
34. Schatz V, Neubert P, Schröder A, Binger K, Gebhard M, Müller DN, Luft FC, Titze J, Jantsch J. 2017; Elementary immunology: Na+ as a regulator of immunity. Pediatr Nephrol. 32:201–210. DOI: 10.1007/s00467-016-3349-x. PMID: 26921211. PMCID: PMC5203836.
pmid
35. Kostyk AG, Dahl KM, Wynes MW, Whittaker LA, Weiss DJ, Loi R, Riches DW. 2006; Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages. Am J Pathol. 169:12–20. DOI: 10.2353/ajpath.2006.051042. PMID: 16816357. PMCID: PMC1698750.
crossref pmid pmc
36. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Krönke M, Mak TW. 1993; Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457–467. DOI: 10.1016/0092-8674(93)90134-C. PMID: 8387893.
crossref pmid
37. Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. 2014; Inducible nitric oxide synthase as a possible target in hypertension. Curr Drug Targets. 15:164–174. DOI: 10.2174/13894501113146660227. PMID: 24102471.
crossref pmid
38. Deanfield JE, Halcox JP, Rabelink TJ. 2007; Endothelial function and dysfunction: testing and clinical relevance. Circulation. 115:1285–1295. DOI: 10.1161/CIRCULATIONAHA.106.652859. PMID: 17353456.
pmid
39. Rainger GE, Nash GB. 2001; Cellular pathology of atherosclerosis: smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res. 88:615–622. DOI: 10.1161/01.RES.88.6.615. PMID: 11282896.
pmid
40. Chen CN, Chang SF, Lee PL, Chang K, Chen LJ, Usami S, Chien S, Chiu JJ. 2006; Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow. Blood. 107:1933–1942. DOI: 10.1182/blood-2005-08-3137. PMID: 16293605. PMCID: PMC1895706.
crossref pmid pmc
41. Vanhoutte PM. 2001; Endothelium-derived free radicals: for worse and for better. J Clin Invest. 107:23–25. DOI: 10.1172/JCI11832. PMID: 11134174. PMCID: PMC198553.
crossref
42. ivastava K Sr, Chandra S, Narang R, Bhatia J, Saluja D. 2018; E-selectin gene in essential hypertension: a case-control study. Eur J Clin Invest. 48:e12868. DOI: 10.1111/eci.12868. PMID: 29178542.
crossref
43. Harwani SC, Ratcliff J, Sutterwala FS, Ballas ZK, Meyerholz DK, Chapleau MW, Abboud FM. 2016; Nicotine mediates CD161a+ renal macrophage infiltration and premature hypertension in the spontaneously hypertensive rat. Circ Res. 119:1101–1115. DOI: 10.1161/CIRCRESAHA.116.309402. PMID: 27660287. PMCID: PMC5085865.
pmid pmc
44. Lin CH, Lee SY, Zhang CC, Du YF, Hung HC, Wu HT, Ou HY. 2016; Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway. Drug Des Devel Ther. 10:3591–3597. DOI: 10.2147/DDDT.S114879. PMID: 27843299. PMCID: PMC5098527.
crossref pmid pmc
45. Durán WN, Breslin JW, Sánchez FA. 2010; The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res. 87:254–261. DOI: 10.1093/cvr/cvq139. PMID: 20462865. PMCID: PMC2895543.
pmid pmc
46. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, Michel T. 1998; Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem. 273:27383–27388. DOI: 10.1074/jbc.273.42.27383. PMID: 9765266.
crossref
47. Wang XP, Cheng ZY, Schmid KL. 2014; GABAB receptors expressed in human aortic endothelial cells mediate intracellular calcium concentration regulation and endothelial nitric oxide synthase translocation. Biomed Res Int. 2014:871735. DOI: 10.1155/2014/871735. PMID: 25114926. PMCID: PMC4119922.
48. Hinds K, Monaghan KP, Frølund B, McGeown JG, Curtis TM. 2013; GABAergic control of arteriolar diameter in the rat retina. Invest Ophthalmol Vis Sci. 54:6798–6805. DOI: 10.1167/iovs.13-12362. PMID: 24045989.
crossref pmid
49. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. 2008; Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 52:1949–1956. DOI: 10.1016/j.jacc.2008.08.050. PMID: 19055985.
pmid
50. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW. 2005; ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood. 106:584–592. DOI: 10.1182/blood-2004-12-4942. PMID: 15811956. PMCID: PMC1635241.
pmid pmc
51. Zhou P, Lu S, Luo Y, Wang S, Yang K, Zhai Y, Sun G, Sun X. 2017; Attenuation of TNF-α-induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-κB, JNK and p38 signaling pathways. Front Pharmacol. 8:464. DOI: 10.3389/fphar.2017.00464. PMID: 28824425. PMCID: PMC5540891.
crossref pmid pmc
52. Pober JS. 2002; Endothelial activation: intracellular signaling pathways. Arthritis Res. 4(Suppl 3):S109–S116. DOI: 10.1186/ar576. PMID: 12110129. PMCID: PMC3240152.
53. Springer TA. 1994; Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301–314. DOI: 10.1016/0092-8674(94)90337-9. PMID: 7507411.
crossref pmid
54. Blann A. 1993; von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci. 50:125–134. PMID: 8219918.
pmid
55. Li X, Li J, Li Z, Sang Y, Niu Y, Zhang Q, Ding H, Yin S. 2016; Fucoidan from Undaria pinnatifida prevents vascular dysfunction through PI3K/Akt/eNOS-dependent mechanisms in the l-NAME-induced hypertensive rat model. Food Funct. 7:2398–2408. DOI: 10.1039/C6FO00288A. PMID: 27153123.
crossref pmid
56. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL. 2007; The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest. 117:1961–1967. DOI: 10.1172/JCI29877. PMID: 17557122. PMCID: PMC1884686.
crossref pmid pmc
57. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999; Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:597–601. DOI: 10.1038/21218. PMID: 10376602. PMCID: PMC3637917.
crossref
58. Wang Q, Zhang M, Ding Y, Wang Q, Zhang W, Song P, Zou MH. 2014; Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. Circ Res. 114:480–492. DOI: 10.1161/CIRCRESAHA.114.302113. PMID: 24281189. PMCID: PMC4104160.
crossref pmid
59. Park S, Lakatta EG. 2012; Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J. 53:258–261. DOI: 10.3349/ymj.2012.53.2.258. PMID: 22318811. PMCID: PMC3282971.
crossref pmid pmc
60. Sen S, Roy S, Bandyopadhyay G, Scott B, Xiao D, Ramadoss S, Mahata SK, Chaudhuri G. 2016; γ-Aminobutyric acid is synthesized and released by the endothelium: potential implications. Circ Res. 119:621–634. DOI: 10.1161/CIRCRESAHA.116.308645. PMID: 27354210.
pmid

Fig. 1

Characteristics of gamma-aminobutyric acid (GABA)-salt.

The HPLC chromatogram shows the (A) base salt and (B) GABA standard and (C) GABA-salt peak. Retention time of GABA standard (B) is 12.28 min and its time of GABA-salt (C) is 12.29 min.
kjpp-25-1-27-f1.tif
Fig. 2

Regulation of blood pressure, water intake, urine volume and renal function of gamma-aminobutyric acid (GABA)-salt in high cholesterol (HCD) diet-induced mouse model.

Blood pressures were measured at 3, 4 and 5 weeks. (A–C) Graphs of the blood pressures of mice fed a normal diet (ND, circle), a high cholesterol diet and normal saline (HCD/salt, square) diet, or a high cholesterol and GABA-salt (HCD/GABA-salt, triangle) diet showing; (A) systolic blood pressures, (B) diastolic blood pressures, and (C) mean arterial blood pressures. (D) Water intake and (E) urine volume were measured at 5 weeks and blood chemistry tests including (F) serum creatinine and (G) BUN show kidney function in ND group, HCD/salt group and HCD/GABA-salt group. BUN, blood urea nitrogen. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. ND; and $p < 0.05, $$p < 0.01, and $$$p < 0.001 vs. HCD/Salt.
kjpp-25-1-27-f2.tif
Fig. 3

Inhibitory effects of gamma-aminobutyric acid (GABA)-salt on expressions of type 1/type 2 macrophage (M1/M2) and associated cytokines in high cholesterol diet (HCD)-induced mouse model.

(A) Immunohistochemistry images showing M1 macrophages (CD86; brown, arrows). Scale bar = 40 µm. (B) The qRT-PCR graph showing mRNA expressions of M1 (CD86) macrophage marker. (C) The qRT-PCR graph showing the mRNA expressions of M1 related cytokines including TNF-α and iNOS. (D) Immunohistochemistry images showing M2 macrophages (CD206; brown, arrow). Scale bar = 40 µm. (E) The qRT-PCR graph showing mRNA expressions of M2 (CD206) macrophage marker. (F) The qRT-PCR graph showing the mRNA expressions of M2 related cytokines including TGF-β and Arg-1. NS, not significant compared to HCD/salt. *p < 0.05, and **p < 0.01 vs. normal diet (ND) and $p < 0.05, and $$p < 0.01 vs. HCD/salt.
kjpp-25-1-27-f3.tif
Fig. 4

Inhibitory effects of gamma-aminobutyric acid (GABA)-salt on the expressions of type 1 macrophages (M1) and associated cytokines in vitro.

(A, B) qRT-PCR graph showing the mRNA expressions of M1 and M2 macrophage marker in media, salt or GABA-salt treated Raw 264.7 cells. (C, D) qRT-PCR graph showing the mRNA expressions of M1 (TNF-α) and M2 (TGF-β) macrophage marker in media, salt or GABA-salt treated Raw 264.7 cells. (E, F) qRT-PCR graph showing the mRNA expressions of M1 (iNOS) and M2 (Arg-1) macrophage marker in media, salt or GABA-salt treated Raw 264.7 cells. NS, not significant compared to salt. *p < 0.05 vs. media; $p < 0.05 vs. salt.
kjpp-25-1-27-f4.tif
Fig. 5

Effects of gamma-aminobutyric acid (GABA)-salt on the expression and function of GABAB receptor in endothelial cell (ECs).

To identify changes in GABAB receptors and in peNOS and eNOS, media, salt or GABA-salt treated ECs and aorta of hypertensive mice were subjected to qRT-PCR and immunofluorescence. (A) The qRT-PCR graph showing the mRNA expressions of GABAB receptor in media, salt or GABA-salt treated SVEC 4–10. (B, C) Immunofluorescent images showing eNOS and peNOS (green, nuclei; blue) expressions in (B) SVEC 4–10 and in (C) the aorta of hypertensive mice (brown, arrows). Scale bar = 50 µm. (D) Immunofluorescent images showing the expression of the adherent proteins such as E-selectin, VCAM-1, ICAM-1 and vWF (green, nuclei; blue) in the aorta of hypertensive mice. Scale bar = 50 µm. (E, F) Apoptotic cells are detected by TUNEL analysis. The fluorescent images and graph showing apoptotic cell in the aorta of hypertensive mice. Scale bar = 50 µm. ICAM-1, Intercellular Adhesion Molecule-1; VCAM-1, vascular cell adhesion molecule-1; vWF, von Willebrand Factor. *p < 0.05, and ***p < 0.001 vs. culture media or normal diet (ND); and $p < 0.05, and $$$p < 0.001 vs. salt or high cholesterol diet (HCD)/salt.
kjpp-25-1-27-f5.tif
Fig. 6

Effects of gamma-aminobutyric acid (GABA)-salt on the expression of GABAB receptor and its function in vascular smooth muscle cells (VSMCs).

(A) The qRT-PCR graph showing the mRNA expressions of GABAB receptor in media, salt or GABA-salt treated mouse vascular smooth muscle cell (MOVAS). (B) Immunofluorescent images showing Endothelin-1 (ET-1) (green, nuclei; blue) expressions in media, salt or GABA-salt treated MOVAS. Scale bar = 50 µm. (C, D) Immunohistochemistry staining image and graph showing proliferating cell nuclear antigen (PCNA), as proliferating cell marker, positive cell (brown, arrows) in hypertensive mice. Scale bar = 50 µm. H&E staining image and graph showing changes of vessel thicknesses in hypertensive mice. Scale bar = 500 µm. *p < 0.05, and **p < 0.01 vs. culture media or normal diet (ND); $p < 0.05 vs. salt or high cholesterol diet (HCD)/salt.
kjpp-25-1-27-f6.tif
TOOLS
Similar articles